of P2Y12 Receptor in Thrombosis

Oct 25, 2017 by in ONCOLOGY Comments Off on of P2Y12 Receptor in Thrombosis

Receptor P2Y1 P2Y12 Distribution [6–10] Platelets, heart, blood vessels, smooth muscle cells, connective and neural tissues, testis Platelets, some neural tissues, nasal mucosa, lymphocytes, endothelium G-coupled protein [11, 12] Gq…

read more

Vein Thrombosis: Recent Advance

Oct 25, 2017 by in ONCOLOGY Comments Off on Vein Thrombosis: Recent Advance

Major risk factors Prevalence Inherited Inherited antithrombin deficiency 3.9 %a Inherited protein C deficiency 5.6 %a Inherited protein S deficiency 2.6 %a Factor V Leiden mutation 6 %–32 %b Prothrombin G20210A mutation 14 %–40 %b Acquired Myeloproliferative…

read more

Management of Peripheral Arterial Disease

Oct 25, 2017 by in ONCOLOGY Comments Off on Management of Peripheral Arterial Disease

Fig. 1 PRISMA diagram Abstracts were screened and included or eliminated by title, abstracts and full texts were screened for the peripheral use of non-invasive medical devices in humans for…

read more

Risk of Thromboembolism in Users of Antidepressants and Antipsychotics

Oct 25, 2017 by in ONCOLOGY Comments Off on Risk of Thromboembolism in Users of Antidepressants and Antipsychotics

Antidepressants  Selective serotonin reuptake inhibitors (SSRI)  Serotonin and norepinephrine reuptake inhibitors (venlafaxine, duloxetine)  Noradrenergic and specific serotonergic antidepressants (mirtazapine, mianserine)  Tricyclic antidepressants Antipsychotics  Typical antipsychotics (First generation)a   Low-potency   High-potency  Atypical…

read more

Risk Factors in Venous Thromboembolism

Oct 25, 2017 by in ONCOLOGY Comments Off on Risk Factors in Venous Thromboembolism

Fig. 1 The prevalence of FV Leiden in European normal population/ VTE (%) (Refs. [17, 19–21]) *In France the frequency ranges from 1.3 % in southwestern to 7.1 % in northeastern regions…

read more

Vein Thrombosis After Splenic and Pancreatic Surgery

Oct 25, 2017 by in ONCOLOGY Comments Off on Vein Thrombosis After Splenic and Pancreatic Surgery

Risk factors Donor Receptor Older 45 years old and cardiovascular disease as cause of death Pancreaticoduodenojejunal anastomosis Asystolia donor Acute failure of graft Unstable haemodynamically Peritoneal dialysis Use of desmopressin…

read more

Thromboembolism in Brain Tumor Patients

Oct 25, 2017 by in ONCOLOGY Comments Off on Thromboembolism in Brain Tumor Patients

Cancer type/Site Diagnoses/100 hospitalizations VTE PE DVT Pancreas 4.3 1.2 3.5 Brain 3.5 1.0 2.8 Myeloproliferative, other lymphatic/hematopoetic 2.9 b 2.5 Stomach 2.7 0.7 2.3 Lymphoma, lymphosarcoma, reticulosarcoma 2.5 0.6…

read more

Therapy in Patients with Chronic Kidney Disease

Oct 25, 2017 by in ONCOLOGY Comments Off on Therapy in Patients with Chronic Kidney Disease

Fig. 1 Mechanism of action of unfractionated heparin, low-molecular-weight heparin, and fondaparinux Only one-third of UFH molecule contain the high-affinity pentasaccharide required for anticoagulant effect [22]. The UFH fraction with…

read more
Get Clinical Tree app for offline access